Stay updated on Pembrolizumab Combo in Endometrial Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo in Endometrial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo in Endometrial Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    A new version entry was added to the record history, indicating an update to the study record. The rest of the page content remains unchanged.
    Difference
    0.0%
    Check dated 2025-10-27T21:04:42.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    Added a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.
    Difference
    8%
    Check dated 2025-10-06T08:18:37.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    Update indicates a new software version (v3.1.0) replacing the old v3.0.2; no substantive content, pricing, or availability changes are detected.
    Difference
    0.2%
    Check dated 2025-09-29T04:49:42.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    The page is updated to v3.0.2 from v3.0.1, and the Back to Top link has been removed; no other core content changes are evident.
    Difference
    0.5%
    Check dated 2025-09-14T22:22:33.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1.
    Difference
    0.5%
    Check dated 2025-09-07T19:36:49.000Z thumbnail image
  8. Check
    58 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location details, which are crucial for users seeking specific information about studies. Additionally, numerous study status updates have been included, enhancing the page's relevance and accuracy.
    Difference
    68%
    Check dated 2025-08-31T12:28:26.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo in Endometrial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Endometrial Cancer Clinical Trial page.